Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

• Status: Completed
• Trial end date: 2009-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Efficacy study of Bromfenac Ophthalmic Solution in cataract surgery

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bausch & Lomb Incorporated
• Treatments: Bromfenac; Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Male or female at least 18 years of age who are scheduled for unilateral cataract surgery

Exclusion Criteria:

• Have known hypersensitivity to bromfenac or to any component of the investigational product